Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Quanex Building Products (NX) Financials

Quanex Building Products logo
$17.45 +0.27 (+1.55%)
As of 12:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Quanex Building Products

Annual Income Statements for Quanex Building Products

This table shows Quanex Building Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 16 -1.86 19 27 -47 38 57 88 83 33 -251
Consolidated Net Income / (Loss)		 16 -1.86 19 27 -47 38 57 88 83 33 -251
Net Income / (Loss) Continuing Operations		 16 -1.86 19 27 -47 38 57 110 83 33 -251
Total Pre-Tax Income 		23 -5.62 26 26 -36 50 80 110 97 42 -243
Total Operating Income		 25 36 34 36 -26 55 82 111 111 55 -194
Total Gross Profit		 146 218 194 193 199 193 241 268 278 306 499
Total Revenue		 646 928 867 890 894 852 1,072 1,222 1,131 1,278 1,838
Operating Revenue		 646 928 867 890 894 852 1,072 1,222 1,131 1,278 1,838
Total Cost of Revenue		 499 711 672 697 694 659 832 953 853 972 1,338
Operating Cost of Revenue		 499 711 672 697 694 659 832 953 853 972 1,338
Total Operating Expenses		 122 181 160 157 226 138 159 157 167 251 693
Selling, General & Admin Expense		 87 115 98 104 101 90 116 117 124 190 277
Depreciation Expense		 35 53 57 52 50 47 43 40 43 60 103
Impairment Charge		 0.00 13 0.00 0.00 75 - - - 0.00 0.00 302
Restructuring Charge		 0.00 0.53 4.55 1.49 0.37 0.62 0.04 0.00 0.00 0.00 10
Total Other Income / (Expense), net		 -1.52 -42 -8.44 -9.94 -9.53 -4.97 -1.78 -1.52 -14 -13 -49
Interest Expense		 0.99 36 9.60 11 9.64 5.25 2.53 2.56 8.14 21 56
Other Income / (Expense), net		 -0.53 -5.48 1.16 1.16 0.12 0.28 0.75 1.04 -5.52 7.85 7.17
Income Tax Expense		 7.54 -3.77 6.82 -0.80 11 12 23 - 15 9.02 8.21
Basic Earnings per Share		 $0.47 ($0.05) $0.55 $0.77 ($1.42) $1.18 $1.72 $2.67 $2.51 $0.91 ($5.43)
Weighted Average Basic Shares Outstanding		 33.99M 33.88M 34.23M 34.70M 32.96M 32.69M 33.19M 33.05M 32.82M 36.42M 46.17M
Diluted Earnings per Share		 $0.47 ($0.05) $0.54 $0.76 ($1.42) $1.17 $1.70 $2.66 $2.50 $0.90 ($5.43)
Weighted Average Diluted Shares Outstanding		 34.50M 33.88M 34.84M 35.03M 32.96M 32.82M 33.50M 33.21M 33.03M 36.65M 46.17M
Weighted Average Basic & Diluted Shares Outstanding		 24.80M -2.40M 34M 34.60M 33.02M 65.66M 66.50M 33.13M 33.00M 47.26M 45.67M
Cash Dividends to Common per Share		 $0.16 $0.16 $0.16 $0.20 $0.32 $0.32 $0.32 $0.32 $0.32 $0.32 $0.32

Quarterly Income Statements for Quanex Building Products

This table shows Quanex Building Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 32 27 6.25 15 25 -14 -15 21 -276 20 -4.07
Consolidated Net Income / (Loss)		 32 27 6.25 15 25 -14 -15 21 -276 20 -4.07
Net Income / (Loss) Continuing Operations		 36 37 7.89 15 25 -13 -15 20 -276 25 -4.07
Total Pre-Tax Income 		36 32 6.85 20 32 -18 -20 27 -284 35 -3.90
Total Operating Income		 37 39 7.92 21 23 2.83 -6.98 41 -271 43 2.85
Total Gross Profit		 79 80 51 66 71 117 92 131 138 138 99
Total Revenue		 300 295 239 266 280 492 400 452 495 490 409
Operating Revenue		 300 295 239 266 280 492 400 452 495 490 409
Total Cost of Revenue		 221 215 188 200 209 375 308 321 357 352 311
Operating Cost of Revenue		 221 215 188 200 209 375 308 321 357 352 311
Total Operating Expenses		 41 41 44 46 47 114 99 90 409 95 96
Selling, General & Admin Expense		 31 29 32 35 37 87 67 70 71 69 71
Depreciation Expense		 11 11 11 11 11 27 25 19 34 26 24
Impairment Charge		 - - - - 0.00 - 0.00 - 302 - 0.00
Restructuring Charge		 - - 0.00 0.00 0.00 - 7.90 0.94 1.37 -0.02 0.00
Total Other Income / (Expense), net		 -1.67 -7.70 -1.07 -0.95 8.60 -20 -13 -14 -13 -8.38 -6.75
Interest Expense		 2.07 1.57 1.07 0.95 0.88 18 14 14 14 13 12
Other Income / (Expense), net		 0.40 - - - 9.47 - 1.23 - 0.86 - 5.62
Income Tax Expense		 4.10 - 1.64 4.31 6.69 - -5.05 6.31 -8.19 15 0.17
Basic Earnings per Share		 $0.97 $0.83 $0.19 $0.47 $0.77 ($0.52) ($0.32) $0.44 ($6.04) $0.49 ($0.09)
Weighted Average Basic Shares Outstanding		 32.72M 32.82M 32.83M 32.87M 32.88M 36.42M 47.02M 46.48M 45.69M 46.17M 45.46M
Diluted Earnings per Share		 $0.96 $0.83 $0.19 $0.46 $0.77 ($0.52) ($0.32) $0.44 ($6.04) $0.49 ($0.09)
Weighted Average Diluted Shares Outstanding		 32.92M 33.03M 33.04M 33.10M 33.11M 36.65M 47.02M 46.56M 45.69M 46.17M 45.46M
Weighted Average Basic & Diluted Shares Outstanding		 32.99M 33.00M 33.10M 33.11M 47.25M 47.26M 47.23M 45.97M 45.88M 45.67M 45.93M
Cash Dividends to Common per Share		 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08

Annual Cash Flow Statements for Quanex Building Products

This table details how cash moves in and out of Quanex Building Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Net Change in Cash & Equivalents		 -97 2.40 -8.07 12 1.87 21 -12 15 3.38 45 -25
Net Cash From Operating Activities		 67 87 80 105 96 101 79 98 147 89 165
Net Cash From Continuing Operating Activities		 67 87 80 105 96 101 79 98 147 95 165
Net Income / (Loss) Continuing Operations		 16 -1.86 19 27 -47 38 57 88 83 33 -251
Consolidated Net Income / (Loss)		 16 -1.86 19 27 -47 38 57 88 83 33 -251
Depreciation Expense		 35 53 57 52 50 47 43 40 43 60 103
Non-Cash Adjustments To Reconcile Net Income		 3.44 19 6.72 1.73 77 0.88 5.01 2.40 2.80 1.20 311
Changes in Operating Assets and Liabilities, net		 12 1.36 -3.01 23 16 14 -26 -33 19 0.73 1.12
Net Cash From Investing Activities		 -160 -282 -33 -26 -24 -25 -19 -33 -128 -421 -62
Net Cash From Continuing Investing Activities		 -160 -282 -33 -26 -24 -25 -19 -33 -128 -421 -62
Purchase of Property, Plant & Equipment		 -30 -37 -35 -26 -25 -26 -24 -33 -37 -37 -63
Acquisitions		 -132 -246 - - - - 0.00 0.00 -91 -399 0.00
Sale of Property, Plant & Equipment		 0.26 1.04 1.94 0.43 1.32 0.50 5.30 0.16 0.25 15 0.63
Net Cash From Financing Activities		 -4.58 195 -55 -66 -71 -55 -72 -46 -16 385 -127
Net Cash From Continuing Financing Activities		 -4.58 195 -55 -66 -71 -55 -72 -46 -16 379 -127
Repayment of Debt		 -69 -436 -102 -299 -138 -155 -66 -98 -103 -394 -269
Repurchase of Common Equity		 -53 0.00 0.00 -32 -9.55 -7.23 -11 -6.60 -5.59 0.00 -32
Payment of Dividends		 -5.52 -5.47 -5.52 -7.02 -11 -11 -11 -11 -11 -12 -15
Issuance of Debt		 117 635 54 269 84 115 0.00 71 102 785 190
Other Financing Activities, net		 5.17 2.61 -1.52 3.79 2.96 3.17 16 -0.72 0.65 -0.62 -1.19
Effect of Exchange Rate Changes		 0.38 1.72 -0.09 -1.19 0.32 0.30 0.42 -4.09 0.92 - -0.29

Quarterly Cash Flow Statements for Quanex Building Products

This table details how cash moves in and out of Quanex Building Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Change in Cash & Equivalents		 30 -15 -14 12 38 9.03 -48 9.33 3.13 10 -13
Net Cash From Operating Activities		 64 44 3.85 33 46 5.48 -13 28 61 88 -20
Net Cash From Continuing Operating Activities		 64 44 3.85 33 46 5.48 -13 28 61 88 -20
Net Income / (Loss) Continuing Operations		 32 27 6.25 15 25 -14 -15 21 -276 20 -4.07
Consolidated Net Income / (Loss)		 32 27 6.25 15 25 -14 -15 21 -276 20 -4.07
Depreciation Expense		 11 11 11 11 11 27 25 19 34 26 24
Non-Cash Adjustments To Reconcile Net Income		 1.87 -1.45 3.51 -0.85 -7.68 0.85 7.08 1.99 305 -3.11 4.27
Changes in Operating Assets and Liabilities, net		 20 7.37 -17 7.67 18 -8.78 -29 -13 -2.40 46 -45
Net Cash From Investing Activities		 -7.29 -15 -9.55 -7.54 -6.23 -397 -11 -15 -14 -21 -11
Net Cash From Continuing Investing Activities		 -7.29 -15 -9.55 -7.54 -6.23 -397 -11 -15 -14 -21 -11
Purchase of Property, Plant & Equipment		 -7.38 -15 -9.58 -7.60 -6.25 -14 -12 -15 -14 -22 -11
Sale of Property, Plant & Equipment		 0.08 0.07 0.03 0.06 0.02 15 0.17 0.21 -0.02 0.27 0.06
Net Cash From Financing Activities		 -28 -43 -9.12 -13 -3.57 411 -22 -8.35 -57 -40 16
Net Cash From Continuing Financing Activities		 -28 -43 -9.12 -13 -3.57 411 -22 -8.35 -57 -40 16
Repayment of Debt		 -26 -41 -5.68 -10 -0.94 -377 -58 -61 -96 -53 -37
Repurchase of Common Equity		 - - 0.00 - - - -3.70 -23 -2.05 -3.11 0.00
Payment of Dividends		 -2.63 -2.69 -2.65 -2.65 -2.65 -4.03 -3.81 -3.74 -3.68 -3.66 -3.64
Issuance of Debt		 - - 0.00 - - 785 45 80 45 20 57
Other Financing Activities, net		 0.65 0.46 -0.79 0.15 0.02 6.51 -1.19 - - - -0.35
Effect of Exchange Rate Changes		 - - 0.76 -1.05 1.23 -9.79 -1.59 3.89 14 -17 2.05

Annual Balance Sheets for Quanex Building Products

This table presents Quanex Building Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Total Assets		 566 780 774 743 645 692 717 725 831 2,320 1,968
Total Current Assets		 158 204 192 191 190 207 249 281 274 611 574
Cash & Equivalents		 23 26 17 29 31 52 40 55 58 98 76
Restricted Cash		 - - - - - - - - 0.00 5.25 2.10
Accounts Receivable		 64 84 79 84 83 88 108 96 97 198 205
Inventories, net		 63 84 88 71 67 61 93 121 98 276 254
Prepaid Expenses		 7.99 10 7.41 7.30 9.35 6.22 8.15 8.66 12 23 32
Other Current Assets		 - - - - - - - - - 5.68 3.76
Plant, Property, & Equipment, net		 141 198 211 201 194 184 179 180 251 402 412
Total Noncurrent Assets		 267 378 371 351 261 300 290 264 307 1,306 983
Goodwill		 130 217 222 220 146 146 149 138 183 575 271
Intangible Assets		 121 154 140 122 107 93 82 65 74 598 549
Noncurrent Deferred & Refundable Income Taxes		 8.78 - - - - - - - 0.00 3.85 2.71
Other Noncurrent Operating Assets		 7.26 6.67 8.98 9.26 8.32 61 58 61 50 130 160
Total Liabilities & Shareholders' Equity		 566 780 774 743 645 692 717 725 831 2,320 1,968
Total Liabilities		 170 413 367 348 315 336 298 260 286 1,309 1,242
Total Current Liabilities		 88 114 106 102 110 130 158 140 135 273 282
Short-Term Debt		 2.36 11 21 1.22 0.75 0.69 0.85 1.05 2.37 26 28
Accounts Payable		 48 48 44 52 64 77 87 78 74 124 131
Accrued Expenses		 37 55 39 46 39 38 56 52 50 104 95
Current Deferred & Payable Income Tax Liabilities		 0.75 0.73 2.19 2.78 6.18 6.47 6.04 1.05 0.38 6.62 12
Other Current Liabilities		 - - - - 0.00 7.46 8.20 7.73 7.22 12 15
Total Noncurrent Liabilities		 82 298 261 246 205 206 140 120 151 1,036 961
Long-Term Debt		 54 259 218 209 156 117 52 30 66 737 665
Noncurrent Deferred & Payable Income Tax Liabilities		 0.56 19 23 18 20 20 23 24 29 162 136
Other Noncurrent Operating Liabilities		 22 12 15 14 16 58 59 63 55 137 159
Commitments & Contingencies		 - - - - - - - - - - 0.00
Total Equity & Noncontrolling Interests		 395 368 407 395 330 356 420 465 546 1,011 726
Total Preferred & Common Equity		 395 368 407 395 330 356 420 465 546 1,011 726
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 395 368 407 395 330 356 420 465 546 1,011 726
Common Stock		 251 255 256 255 255 254 255 252 252 702 701
Retained Earnings		 222 214 226 244 186 214 260 337 409 430 165
Treasury Stock		 -68 -62 -50 -73 -77 -79 -73 -76 -78 -75 -104
Accumulated Other Comprehensive Income / (Loss)		 -10 -39 -25 -31 -34 -33 -22 -49 -38 -46 -35

Quarterly Balance Sheets for Quanex Building Products

This table presents Quanex Building Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 7/31/2022 1/31/2023 4/30/2023 7/31/2023 1/31/2024 4/30/2024 7/31/2024 1/31/2025 4/30/2025 7/31/2025 1/31/2026
Total Assets		 744 827 822 848 813 837 872 2,220 2,308 1,973 1,978
Total Current Assets		 306 267 264 288 253 264 301 548 588 583 569
Cash & Equivalents		 50 43 43 73 44 56 94 50 63 66 62
Restricted Cash		 - - - - - - - 5.49 2.17 1.65 2.33
Accounts Receivable		 109 85 94 96 80 87 88 164 195 202 189
Inventories, net		 138 128 114 105 107 101 99 281 279 272 271
Prepaid Expenses		 8.65 11 12 13 13 13 19 42 43 41 40
Other Current Assets		 - - - - - - - - - - 4.35
Plant, Property, & Equipment, net		 175 242 243 246 254 253 252 391 417 406 402
Total Noncurrent Assets		 262 318 316 314 307 321 319 1,282 1,303 984 1,008
Goodwill		 141 185 185 186 185 184 186 570 579 271 275
Intangible Assets		 70 83 81 79 72 69 67 580 567 559 544
Noncurrent Deferred & Refundable Income Taxes		 - - - - - - - 3.71 4.05 3.65 2.96
Other Noncurrent Operating Assets		 51 50 50 49 49 68 66 128 152 150 185
Total Liabilities & Shareholders' Equity		 744 827 822 848 813 837 872 2,220 2,308 1,973 1,978
Total Liabilities		 293 351 329 322 258 271 278 1,248 1,307 1,255 1,248
Total Current Liabilities		 159 120 119 135 111 119 128 229 244 265 246
Short-Term Debt		 1.07 2.00 2.11 2.28 2.50 2.63 2.69 26 26 26 29
Accounts Payable		 85 63 64 71 55 61 64 108 112 126 116
Accrued Expenses		 51 46 45 54 46 49 55 81 92 95 77
Current Deferred & Payable Income Tax Liabilities		 14 1.62 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.27 7.10
Other Current Liabilities		 7.97 7.21 7.40 7.39 7.37 6.43 6.44 13 14 15 17
Total Noncurrent Liabilities		 135 231 211 186 147 153 150 1,020 1,062 991 1,002
Long-Term Debt		 55 152 132 107 62 52 51 725 746 696 679
Noncurrent Deferred & Payable Income Tax Liabilities		 21 23 23 24 31 29 27 163 164 144 140
Other Noncurrent Operating Liabilities		 54 56 55 56 55 72 72 132 152 151 184
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 450 476 493 526 555 566 594 972 1,002 717 730
Total Preferred & Common Equity		 450 476 493 526 555 566 594 972 1,002 717 730
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 450 476 493 526 555 566 594 972 1,002 717 730
Common Stock		 252 250 251 251 249 250 251 698 699 700 696
Retained Earnings		 315 337 356 385 413 426 448 412 428 149 157
Treasury Stock		 -76 -73 -79 -78 -75 -75 -75 -75 -99 -101 -98
Accumulated Other Comprehensive Income / (Loss)		 -41 -38 -35 -32 -32 -35 -30 -62 -27 -31 -24

Annual Metrics And Ratios for Quanex Building Products

This table displays calculated financial ratios and metrics derived from Quanex Building Products' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/31/2015 10/31/2016 10/31/2017 10/31/2018 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024 10/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.42% 43.79% -6.64% 2.68% 0.46% -4.73% 25.90% 13.93% -7.44% 13.03% 43.81%
EBITDA Growth		 15.77% 68.52% -7.45% -3.08% -74.06% 341.56% 21.97% 21.60% -2.88% -16.92% -167.75%
EBIT Growth		 68.04% 27.87% 13.68% 5.00% -171.39% 311.11% 48.75% 35.94% -6.36% -40.41% -398.02%
NOPAT Growth		 93.00% 52.92% -2.30% 48.04% -150.26% 328.64% 37.70% 91.06% -0.52% -50.47% -415.22%
Net Income Growth		 -44.95% -111.55% 1,105.00% 42.12% -275.99% 182.38% 48.02% 55.03% -6.61% -59.93% -858.66%
EPS Growth		 -39.74% -110.64% 1,180.00% 40.74% -286.84% 182.39% 45.30% 56.47% -6.02% -64.00% -703.33%
Operating Cash Flow Growth		 222.88% 30.19% -8.66% 31.13% -7.88% 4.59% -22.03% 24.66% 50.11% -39.61% 85.67%
Free Cash Flow Firm Growth		 -2,795.79% -43.29% 104.98% 1,027.44% 14.57% -24.15% -38.95% 119.61% -104.60% -22,154.63% 118.10%
Invested Capital Growth		 42.14% 42.85% 2.78% -8.28% -20.86% -7.65% 2.63% 1.79% 26.22% 200.55% -19.74%
Revenue Q/Q Growth		 5.15% 6.14% -1.84% 1.27% -0.41% 1.80% 3.51% 1.31% -1.05% 18.19% -0.13%
EBITDA Q/Q Growth		 27.97% -6.13% 12.43% -3.37% -60.35% 97.68% -1.55% 1.25% 5.00% -9.35% 35.36%
EBIT Q/Q Growth		 78.47% -23.30% 38.89% -7.41% -392.57% 1,396.36% -0.95% 2.29% 5.42% -31.50% 20.20%
NOPAT Q/Q Growth		 85.24% 18.26% 13.50% -7.53% -393.86% 1,527.77% -29.49% 1.35% 10.95% -40.08% 17.14%
Net Income Q/Q Growth		 44.90% -170.07% 39.61% -13.13% -415.50% 363.60% -2.15% 4.46% 3.40% -55.54% 11.78%
EPS Q/Q Growth		 42.42% -171.43% 38.46% -14.61% -389.66% 365.91% -2.86% 4.72% 3.73% -60.00% 15.68%
Operating Cash Flow Q/Q Growth		 63.23% 1.48% -5.86% 27.94% 11.81% -11.50% -21.94% 20.93% -2.40% -30.52% 100.80%
Free Cash Flow Firm Q/Q Growth		 16.50% 6.65% -66.58% 48.22% 20.11% -17.55% -52.49% 17.41% 17.99% -1,165.91% 119.78%
Invested Capital Q/Q Growth		 -5.26% -4.84% -1.94% -7.14% -15.88% -6.66% -0.54% -3.55% -1.13% 201.42% -2.22%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 22.68% 23.44% 22.40% 21.66% 22.31% 22.64% 22.44% 21.98% 24.55% 23.92% 27.17%
EBITDA Margin		 9.20% 10.78% 10.69% 10.09% 2.60% 12.07% 11.69% 12.48% 13.09% 9.63% -4.54%
Operating Margin		 3.82% 3.92% 3.92% 4.01% -2.96% 6.49% 7.64% 9.11% 9.79% 4.29% -10.55%
EBIT Margin		 3.74% 3.33% 4.05% 4.14% -2.94% 6.52% 7.71% 9.20% 9.30% 4.90% -10.16%
Profit (Net Income) Margin		 2.49% -0.20% 2.16% 2.98% -5.23% 4.52% 5.31% 7.23% 7.30% 2.59% -13.65%
Tax Burden Percent		 69.51% 33.05% 73.26% 103.11% 129.97% 76.53% 71.14% 80.48% 85.01% 78.56% 103.39%
Interest Burden Percent		 95.90% -18.22% 72.66% 69.88% 136.65% 90.56% 96.94% 97.72% 92.26% 67.14% 129.88%
Effective Tax Rate		 32.56% 0.00% 26.74% -3.11% 0.00% 23.47% 28.86% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 4.56% 4.89% 4.01% 6.11% -3.58% 9.63% 13.64% 25.49% 22.22% 4.92% -9.02%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.83% -14.82% 1.36% 1.02% -21.92% 5.68% 10.42% 423.15% 422.42% -1.57% -27.07%
Return on Net Nonoperating Assets (RNNOA)		 -0.62% -5.38% 0.82% 0.52% -9.30% 1.59% 1.06% -5.52% -5.89% -0.68% -19.86%
Return on Equity (ROE)		 3.94% -0.49% 4.82% 6.62% -12.88% 11.22% 14.69% 19.97% 16.33% 4.25% -28.88%
Cash Return on Invested Capital (CROIC)		 -30.24% -30.40% 1.27% 14.74% 19.70% 17.59% 11.04% 23.72% -0.96% -95.21% 12.89%
Operating Return on Assets (OROA)		 4.46% 4.59% 4.52% 4.86% -3.79% 8.31% 11.73% 15.58% 13.52% 3.98% -8.71%
Return on Assets (ROA)		 2.97% -0.28% 2.40% 3.50% -6.73% 5.76% 8.09% 12.25% 10.61% 2.10% -11.70%
Return on Common Equity (ROCE)		 3.94% -0.49% 4.82% 6.62% -12.88% 11.22% 14.69% 19.97% 16.33% 4.25% -28.88%
Return on Equity Simple (ROE_SIMPLE)		 4.07% -0.51% 4.59% 6.72% -14.15% 10.82% 13.57% 19.00% 15.12% 3.27% 0.00%
Net Operating Profit after Tax (NOPAT)		 17 25 25 37 -18 42 58 111 111 55 -136
NOPAT Margin		 2.58% 2.74% 2.87% 4.14% -2.07% 4.97% 5.43% 9.11% 9.79% 4.29% -7.39%
Net Nonoperating Expense Percent (NNEP)		 -1.26% 19.72% 2.65% 5.08% 18.34% 3.96% 3.21% -397.66% -400.20% 6.50% 18.05%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 22.46% 18.02% 3.09% -9.57%
Cost of Revenue to Revenue		 77.32% 76.56% 77.60% 78.34% 77.69% 77.36% 77.56% 78.02% 75.45% 76.08% 72.83%
SG&A Expenses to Revenue		 13.41% 12.38% 11.32% 11.66% 11.33% 10.53% 10.82% 9.59% 10.96% 14.91% 15.09%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 18.86% 19.52% 18.48% 17.65% 25.27% 16.15% 14.81% 12.87% 14.76% 19.63% 37.72%
Earnings before Interest and Taxes (EBIT)		 24 31 35 37 -26 56 83 112 105 63 -187
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 59 100 93 90 23 103 125 152 148 123 -83
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.44 1.36 1.70 1.21 1.81 1.60 1.60 1.54 1.60 1.35 0.90
Price to Tangible Book Value (P/TBV)		 3.94 0.00 15.38 8.87 7.71 4.88 3.56 2.73 3.03 0.00 0.00
Price to Revenue (P/Rev)		 0.88 0.54 0.80 0.54 0.67 0.67 0.63 0.59 0.77 1.07 0.35
Price to Earnings (P/E)		 35.39 0.00 36.93 17.94 0.00 14.77 11.77 8.09 10.59 41.42 0.00
Dividend Yield		 0.95% 1.09% 0.81% 1.48% 1.78% 1.85% 1.60% 1.48% 1.21% 1.10% 2.25%
Earnings Yield		 2.83% 0.00% 2.71% 5.57% 0.00% 6.77% 8.50% 12.36% 9.44% 2.41% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.41 1.22 1.45 1.14 1.58 1.51 1.58 1.57 1.59 1.21 0.94
Enterprise Value to Revenue (EV/Rev)		 0.93 0.80 1.05 0.74 0.81 0.75 0.64 0.57 0.78 1.59 0.69
Enterprise Value to EBITDA (EV/EBITDA)		 10.15 7.44 9.85 7.33 31.05 6.17 5.45 4.53 5.97 16.50 0.00
Enterprise Value to EBIT (EV/EBIT)		 24.95 24.12 25.98 17.85 0.00 11.42 8.27 6.15 8.41 32.38 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 36.21 29.27 36.68 17.87 0.00 15.00 11.73 6.20 7.99 37.01 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.98 8.53 11.43 6.29 7.50 6.29 8.70 7.05 6.01 22.85 7.68
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 115.72 7.40 7.10 8.22 14.50 6.67 0.00 0.00 6.53
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.14 0.73 0.59 0.53 0.48 0.33 0.13 0.07 0.13 0.75 0.95
Long-Term Debt to Equity		 0.14 0.70 0.54 0.53 0.47 0.33 0.12 0.06 0.12 0.73 0.92
Financial Leverage		 -0.11 0.36 0.60 0.50 0.42 0.28 0.10 -0.01 -0.01 0.43 0.73
Leverage Ratio		 1.33 1.76 2.01 1.89 1.91 1.95 1.82 1.63 1.54 2.02 2.47
Compound Leverage Factor		 1.27 -0.32 1.46 1.32 2.62 1.76 1.76 1.59 1.42 1.36 3.21
Debt to Total Capital		 12.43% 42.29% 37.05% 34.76% 32.25% 24.82% 11.20% 6.19% 11.20% 43.01% 48.82%
Short-Term Debt to Total Capital		 0.52% 1.65% 3.29% 0.20% 0.15% 0.15% 0.18% 0.21% 0.39% 1.45% 1.94%
Long-Term Debt to Total Capital		 11.91% 40.64% 33.76% 34.56% 32.10% 24.67% 11.02% 5.98% 10.81% 41.56% 46.88%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 87.57% 57.71% 62.95% 65.24% 67.75% 75.18% 88.80% 93.81% 88.80% 56.99% 51.18%
Debt to EBITDA		 0.95 2.69 2.59 2.35 6.75 1.14 0.42 0.20 0.46 6.20 -8.31
Net Debt to EBITDA		 0.56 2.44 2.40 2.02 5.43 0.64 0.10 -0.16 0.07 5.37 -7.38
Long-Term Debt to EBITDA		 0.91 2.59 2.36 2.33 6.72 1.14 0.42 0.19 0.45 5.99 -7.98
Debt to NOPAT		 3.37 10.59 9.63 5.72 -8.50 2.78 0.91 0.28 0.62 13.92 -5.10
Net Debt to NOPAT		 1.98 9.59 8.93 4.93 -6.83 1.56 0.22 -0.22 0.09 12.04 -4.53
Long-Term Debt to NOPAT		 3.23 10.18 8.78 5.69 -8.46 2.76 0.89 0.27 0.60 13.45 -4.90
Altman Z-Score		 3.99 2.57 2.94 2.78 2.94 3.08 3.89 4.73 4.50 1.70 1.23
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.79 1.79 1.80 1.87 1.73 1.59 1.58 2.01 2.03 2.24 2.04
Quick Ratio		 0.99 0.96 0.91 1.10 1.04 1.07 0.94 1.08 1.16 1.08 1.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -110 -158 7.88 89 102 77 47 104 -4.76 -1,060 194
Operating Cash Flow to CapEx		 225.75% 241.28% 244.52% 401.55% 409.07% 399.60% 420.08% 297.21% 395.97% 402.96% 265.93%
Free Cash Flow to Firm to Interest Expense		 -111.34 -4.33 0.82 8.00 10.56 14.72 18.63 40.46 -0.59 -51.47 3.48
Operating Cash Flow to Interest Expense		 67.70 2.39 8.31 9.42 9.99 19.22 31.06 38.28 18.07 4.31 2.95
Operating Cash Flow Less CapEx to Interest Expense		 37.71 1.40 4.91 7.08 7.55 14.41 23.67 25.40 13.51 3.24 1.84
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.19 1.38 1.12 1.17 1.29 1.27 1.52 1.69 1.45 0.81 0.86
Accounts Receivable Turnover		 10.82 12.57 10.63 10.89 10.71 9.95 10.91 11.96 11.70 8.66 9.12
Inventory Turnover		 8.29 9.64 7.83 8.81 10.07 10.27 10.82 8.93 7.80 5.21 5.05
Fixed Asset Turnover		 5.16 5.47 4.23 4.31 4.53 4.51 5.91 6.80 5.25 3.91 4.51
Accounts Payable Turnover		 11.18 14.87 14.63 14.44 11.97 9.35 10.13 11.57 11.20 9.78 10.47
Days Sales Outstanding (DSO)		 33.72 29.04 34.34 33.52 34.09 36.70 33.46 30.53 31.21 42.13 40.03
Days Inventory Outstanding (DIO)		 44.02 37.84 46.64 41.44 36.24 35.56 33.74 40.87 46.82 70.11 72.22
Days Payable Outstanding (DPO)		 32.64 24.54 24.95 25.28 30.48 39.05 36.02 31.53 32.58 37.31 34.87
Cash Conversion Cycle (CCC)		 45.10 42.35 56.03 49.68 39.84 33.21 31.18 39.86 45.45 74.93 77.39
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 428 612 629 577 456 422 433 440 556 1,671 1,341
Invested Capital Turnover		 1.77 1.78 1.40 1.48 1.73 1.94 2.51 2.80 2.27 1.15 1.22
Increase / (Decrease) in Invested Capital		 127 184 17 -52 -120 -35 11 7.76 115 1,115 -330
Enterprise Value (EV)		 602 745 912 658 723 634 683 690 884 2,029 1,267
Market Capitalization		 569 501 690 476 597 569 670 715 874 1,369 652
Book Value per Share		 $11.65 $10.75 $11.71 $11.24 $9.96 $10.84 $12.52 $14.03 $16.54 $21.39 $15.83
Tangible Book Value per Share		 $4.27 ($0.10) $1.29 $1.53 $2.33 $3.55 $5.61 $7.91 $8.75 ($3.43) ($2.06)
Total Capital		 451 637 646 606 487 473 473 496 614 1,774 1,419
Total Debt		 56 270 239 211 157 117 53 31 69 763 693
Total Long-Term Debt		 54 259 218 209 156 117 52 30 66 737 665
Net Debt		 33 244 222 182 126 66 13 -24 10 660 615
Capital Expenditures (CapEx)		 30 36 33 26 24 25 19 33 37 22 62
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 49 75 89 61 50 26 52 87 83 261 242
Debt-free Net Working Capital (DFNWC)		 72 100 107 90 81 78 92 142 141 364 320
Net Working Capital (NWC)		 70 90 85 89 81 77 91 141 139 338 292
Net Nonoperating Expense (NNE)		 0.55 27 6.18 10 28 3.80 1.26 23 28 22 115
Net Nonoperating Obligations (NNO)		 33 244 222 182 126 66 13 -24 10 660 615
Total Depreciation and Amortization (D&A)		 35 69 57 53 50 47 43 40 43 60 103
Debt-free, Cash-free Net Working Capital to Revenue		 7.62% 8.06% 10.29% 6.84% 5.64% 3.07% 4.83% 7.10% 7.33% 20.44% 13.15%
Debt-free Net Working Capital to Revenue		 11.21% 10.81% 12.30% 10.10% 9.10% 9.13% 8.57% 11.61% 12.50% 28.50% 17.40%
Net Working Capital to Revenue		 10.84% 9.68% 9.85% 9.97% 9.01% 9.05% 8.49% 11.53% 12.29% 26.48% 15.90%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.47 ($0.05) $0.55 $0.76 ($1.42) $1.18 $1.72 $0.00 $2.51 $0.91 ($5.43)
Adjusted Weighted Average Basic Shares Outstanding		 33.99M 33.88M 34.23M 34.70M 32.96M 32.69M 33.19M 0.00 32.82M 36.42M 46.17M
Adjusted Diluted Earnings per Share		 $0.47 ($0.05) $0.54 $0.75 ($1.42) $1.17 $1.70 $0.00 $2.50 $0.90 ($5.43)
Adjusted Weighted Average Diluted Shares Outstanding		 34.50M 33.88M 34.84M 35.03M 32.96M 32.82M 33.50M 0.00 33.03M 36.65M 46.17M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 33.97M 34.20M 34.85M 33.50M 33.02M 65.66M 66.50M 0.00 33.00M 47.26M 45.67M
Normalized Net Operating Profit after Tax (NOPAT)		 17 35 28 26 34 43 58 78 77 38 83
Normalized NOPAT Margin		 2.58% 3.73% 3.25% 2.93% 3.80% 5.02% 5.44% 6.38% 6.85% 3.00% 4.51%
Pre Tax Income Margin		 3.59% -0.61% 2.94% 2.89% -4.02% 5.91% 7.47% 8.99% 8.58% 3.29% -13.20%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 24.36 0.85 3.66 3.32 -2.73 10.59 32.66 43.89 12.93 3.04 -3.35
NOPAT to Interest Expense		 16.79 0.70 2.59 3.32 -1.92 8.06 23.02 43.49 13.61 2.66 -2.43
EBIT Less CapEx to Interest Expense		 -5.62 -0.15 0.26 0.97 -5.17 5.78 25.26 31.01 8.36 1.97 -4.46
NOPAT Less CapEx to Interest Expense		 -13.20 -0.29 -0.81 0.97 -4.36 3.25 15.63 30.61 9.04 1.59 -3.54
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 34.27% -294.24% 29.52% 26.44% -22.78% 27.36% 18.92% 12.00% 12.90% 36.21% -5.94%
Augmented Payout Ratio		 361.86% -294.24% 29.52% 147.08% -43.22% 46.15% 38.54% 19.47% 19.67% 36.21% -18.84%

Quarterly Metrics And Ratios for Quanex Building Products

This table displays calculated financial ratios and metrics derived from Quanex Building Products' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 45,674,726.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 45,674,726.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.09
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 33 39 6.02 16 19 1.98 -4.88 31 -190 24 2.00
Return On Investment Capital (ROIC_SIMPLE)		 - 6.43% 0.97% - - 0.11% -0.28% 1.76% -13.17% 1.71% 0.14%
Earnings before Interest and Taxes (EBIT)		 38 39 7.92 21 33 2.83 -5.75 41 -270 43 8.47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 48 51 19 32 44 30 19 60 -236 69 33
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -72 -76 18 35 26 -1,113 -1,098 -1,114 -1,007 354 297
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 562 556 575 564 554 1,671 1,668 1,709 1,371 1,341 1,373
Increase / (Decrease) in Invested Capital		 106 115 -12 -19 -7.95 1,115 1,093 1,145 817 -330 -295
Book Value per Share		 $15.96 $16.54 $16.91 $17.10 $17.94 $21.39 $20.57 $21.21 $15.60 $15.83 $15.99
Tangible Book Value per Share		 $7.92 $8.75 $9.07 $9.45 $10.31 ($3.43) ($3.76) ($3.06) ($2.45) ($2.06) ($1.96)
Total Capital		 635 614 619 620 648 1,774 1,723 1,774 1,439 1,419 1,438
Total Debt		 110 69 64 54 54 763 751 773 722 693 707
Total Long-Term Debt		 107 66 62 52 51 737 725 746 696 665 679
Net Debt		 36 10 20 -1.97 -40 660 696 708 654 615 643
Capital Expenditures (CapEx)		 7.29 15 9.55 7.54 6.23 -1.28 11 15 14 21 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 81 83 100 91 82 261 289 305 277 242 287
Debt-free Net Working Capital (DFNWC)		 154 141 144 148 176 364 345 370 345 320 351
Net Working Capital (NWC)		 152 139 142 145 174 338 319 344 319 292 323
Net Nonoperating Expense (NNE)		 1.48 12 -0.23 0.74 -6.80 16 10 11 86 4.63 6.07
Net Nonoperating Obligations (NNO)		 36 10 20 -1.97 -40 660 696 708 654 615 643
Total Depreciation and Amortization (D&A)		 11 11 11 11 11 27 25 19 34 26 24
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.97 $0.83 $0.19 $0.47 $0.77 ($0.52) ($0.32) $0.44 ($6.04) $0.49 ($0.09)
Adjusted Weighted Average Basic Shares Outstanding		 32.72M 32.82M 32.83M 32.87M 32.88M 36.42M 47.02M 46.48M 45.69M 46.17M 45.46M
Adjusted Diluted Earnings per Share		 $0.96 $0.83 $0.19 $0.46 $0.77 ($0.52) ($0.32) $0.44 ($6.04) $0.49 ($0.09)
Adjusted Weighted Average Diluted Shares Outstanding		 32.92M 33.03M 33.04M 33.10M 33.11M 36.65M 47.02M 46.56M 45.69M 46.17M 45.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 32.99M 33.00M 33.10M 33.11M 47.25M 47.26M 47.23M 45.97M 45.88M 45.67M 45.93M
Normalized Net Operating Profit after Tax (NOPAT)		 33 28 6.02 16 19 1.98 0.65 32 23 24 2.00
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Here are the most relevant four-year trends for Quanex Building Products (NX) based on quarterly data from 2022 through 2025. The focus is on what may impact retail investors: cash generation, profitability, leverage, and overall financial health.

  • Net cash from continuing operating activities has trended up in 2025, rising from about $28.5M in Q2 to about $88.3M in Q4 2025, signaling improving core cash generation. (Q2 2025 CFO: 28.5M; Q4 2025 CFO: 88.3M)
  • Free cash flow turned positive in Q4 2025, estimated around $66.6M (approximately CFO 88.3M minus capex of about $21.6M), indicating meaningful cash available after sustaining capital expenditures. (Q4 2025 CFO: 88.3M; Capex: -21.6M)
  • Q4 2025 net income attributable to common shareholders was about $19.6M, showing a return to profitability in the quarter after a heavier impairment impact in the prior quarter. (Q4 2025 net income: 19.57M)
  • Revenue in 2025 showed a clear year-over-year quarter pattern, increasing from around $400.0M in Q1 2025 to about $490.0M in Q4 2025, pointing to improving top-line momentum. (Q1 2025 revenue: 400.0M; Q4 2025 revenue: 489.8M)
  • Gross margin remains broadly in the high-20s (around 27–29%) in late 2025, with Q4 2025 gross profit of about $137.6M on $489.8M in revenue (roughly 28%), indicating relatively stable gross profitability despite quarterly swings. (Q4 2025 gross profit: 137.6M; gross margin ≈ 28%)
  • One-time impairment charge in Q3 2025 was substantial (about $302.3M), weighing on quarterly earnings but not indicative of ongoing operating performance. (Q3 2025 impairment: 302.284M)
  • Long-term debt has remained elevated and relatively steady around $695–746M through 2025, suggesting leverage remains a material consideration for investors. (Long-term debt: ~$696–$746M in 2025)
  • Dividends per share were maintained at $0.08, reflecting a stable capital return policy despite earnings volatility. (Cash dividends per share: 0.08)
  • Q3 2025 was notably weak: total operating income was negative at about -$270.8M and net income attributable to common shareholders was deeply negative around -$276.0M, driven largely by the impairment and related charges. (Q3 2025 operating income: -270.8M; Q3 2025 net income to common: -276.0M)
  • Q1 2025 and several earlier quarters show softer quarterly earnings, including a negative net income in Q1 2025 from continuing operations, highlighting quarterly volatility prior to the Q4 2025 rebound. (Q1 2025 net income continuing operations: negative; Q4 2024 and earlier quarters show more variability)
05/22/26 12:05 PM ETAI Generated. May Contain Errors.

Quanex Building Products Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Quanex Building Products' fiscal year ends in October. Their fiscal year 2025 ended on October 31, 2025.

Quanex Building Products' net income appears to be on a downward trend, with a most recent value of -$250.81 million in 2025, falling from $16.09 million in 2015. The previous period was $33.06 million in 2024. Check out Quanex Building Products' forecast to explore projected trends and price targets.

Quanex Building Products' total operating income in 2025 was -$193.95 million, based on the following breakdown:
  • Total Gross Profit: $499.23 million
  • Total Operating Expenses: $693.18 million

Over the last 10 years, Quanex Building Products' total revenue changed from $645.53 million in 2015 to $1.84 billion in 2025, a change of 184.7%.

Quanex Building Products' total liabilities were at $1.24 billion at the end of 2025, a 5.1% decrease from 2024, and a 629.7% increase since 2015.

In the past 10 years, Quanex Building Products' cash and equivalents has ranged from $17.46 million in 2017 to $97.74 million in 2024, and is currently $76.02 million as of their latest financial filing in 2025.

Over the last 10 years, Quanex Building Products' book value per share changed from 11.65 in 2015 to 15.83 in 2025, a change of 35.8%.


Related Companies

Financial statements for NYSE:NX last updated on 3/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
System failure: The strongest leverage for gold…
$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...
Golden Portfolio | Sponsoredtc pixel
I had never heard of this 1888 account
An investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...
The Oxford Club | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
How to Profit from Elon’s AI lab before it goes public
Elon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...
InvestorPlace | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
One coin wired into Elon's vision
SpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...
Crypto 101 Media | Sponsoredtc pixel